Genomics USA, an Illinois-base company, has recently located its research and development headquarters to Tucson, Ariz. The company develops microarray chips for population-scale genetic analysis. It will be located on the campus of the University of Arizona.

The technology that Genomics USA has invented is centered on a platform which dramatically reduces microarray manufacturing costs and allows for microarray products that can be used as part of a very simple and very inexpensive genetic test. Genomics USA’s microarray technology will deliver the power of multiple–gene analysis at a cost and quality high enough to become the basis for routine population scale diagnostic testing.

A Microarray uses a robot to precisely apply tiny droplets containing functional DNA to glass slides. Researchers then attach fluorescent labels to DNA from the cell they are studying. This powerful technology allows simultaneous measurement of expression levels for up to tens of thousands of genes.

Dr. Michael Hogan, Chief Scientific Officer of Genomics USA, cited the proximity to the rich biochemical and biotech research resources of the University of Arizona, the energetic local commercial biotechnology community and access to top local research collaborators as the driving force behind moving the Genomics USA research and development laboratories to Tucson.

For MORE NEWS BRIEFS, click here.

For a FREE SUBSCRIPTION to Expansion Management, click here.

Go to STATE SPOTLIGHTS to read more about other news and articles about this state.

Go to INDUSTRY SPOTLIGHTS to read more about other news and articles about this industry sector.